FOI release

Question about the CHM puberty blocker report

Some or all of the information requested was not provided because we didn't hold it.

Case reference FOI2025/00080

Received 29 January 2025

Published 31 March 2025

Request

We are writing with a question for the authors of the CHM report on the safety implications of restricting the supply of GnRHa to minors in response to gender dysphoria: https://www.gov.uk/government/publications/chms-report-on-proposed-changes-to-the-availability-of-puberty-blockers The source text we are referring to is the PDF version of the CHM report here: https://assets.publishing.service.gov.uk/media/678e6994ea48a571517acf98/chm-advice-to-sos-on-gnrh-agonists-for_pubertal-suppression.pdf Item 16 on page 7 of the report includes the claim "One in 18 do regret the decision and may have lifelong impact from GnRH agonist use." No reference is provided, which means it is not possible to verify the veracity of that claim. Please could you supply details of the source(s) on which this claim is based.

Response

see attached

Documents

• FOI2025_00080 redacted for publication.pdf (119.1 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.